# US 2024/0069049 A1 · Performing antimicrobial susceptibility testing and related systems and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0069049 A1
- Document ID: US20240069049A1
- Status: Published application
- Kind: A1
- Application number: 18/488,369
- Filed: 2023-10-17
- Published: 2024-02-29
- Earliest claimed: 2016-04-22
- Assignees: Selux Diagnostics, Inc.
- Applicants: SeLux Diagnostics, Inc.
- Inventors: Aleksandar Vacic; Nathan Purmort; Eric Stern; Anna Passernig; Paul Otten; Randy Tragni; Ronan Hayes; Andriy Tsupryk; Bruce Richardson
- Web page: https://patentgrep.com/patent/US20240069049A1

## CPC

- G01N 35/02: using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations {(G01N35/0098 and G01N35/0099 take precedence)}
- B01J 20/041: {Oxides or hydroxides}
- C12Q 1/18: Testing for antimicrobial activity of a material
- G01N 15/02: Investigating particle size or size distribution (by measuring osmotic pressure G01N7/10; investigating sedimentation of particle suspensions G01N15/04; investigating individual particles G01N15/10)
- G01N 21/01: Arrangements or apparatus for facilitating the optical investigation
- G01N 35/00: Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N 35/00029: {provided with flat sample substrates, e.g. slides (G01N35/028 takes precedence)}
- G01N 35/0099: {comprising robots or similar manipulators (robots per se B25J)}
- G01N 35/028: {having reaction cells in the form of microtitration plates}
- G01N 35/1065: {Multiple transfer devices}
- C12M 33/10: {by centrifugation (centrifuges in general B04B); Cyclones (cyclones in general B04C)}
- C12M 41/36: {of biomass, e.g. colony counters or by turbidity measurements (electrooptical investigation of individual particles G01N15/14, flow cytometers G01N15/1404)}
- C12M 41/48: {Automatic or computerized control (automatic analysis G01N35/00)}
- C12M 47/02: {Separating microorganisms from the culture medium; Concentration of biomass (separating microorganisms from their culture media C12N1/02)}
- G01N 2021/0112: {Apparatus in one mechanical, optical or electronic block}
- G01N 2035/00039: {Transport arrangements specific to flat sample substrates, e.g. pusher blade}
- G01N 2035/00118: {for multiple tests}
- G01N 2035/00148: {Test cards, e.g. Biomerieux or McDonnel multiwell test cards}
- G01N 2035/00237: {Handling microquantities of analyte, e.g. microvalves, capillary networks}
- G01N 2035/00346: {Heating or cooling arrangements}
- G01N 2035/00356: {Holding samples at elevated temperature (incubation)}
- G01N 2035/00465: {Separating and mixing arrangements}
- G01N 2035/00485: {combined with sample carriers}
- G01N 2035/00524: {Mixing by agitating sample carrier}
- G01N 2035/00841: {results of the analyses}
- G01N 2035/0425: {Stacks, magazines or elevators for plates}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}

## Abstract

In some aspects, automated rapid antimicrobial susceptibility testing systems for performing a multi-assay testing sequence can include an automated incubation assembly having a nest assembly adapted to house at least one test panel having a plurality of wells for receiving a sample comprising microorganisms originating from a clinical sample, the incubation assembly facilitating incubation of one or more test panels in order to undergo the multi-assay testing sequence; a robotic handling assembly configured to accept one or more incoming test panels and move them to and from the incubation assembly for incubation between each assay of the multi-assay testing sequence; an automated liquid handling assembly configured to exchange one or more fluids in the plurality of wells of the test panels; and an optical assembly for interrogation and readout of each assay of the multi-assay testing sequence being performed in the plurality of wells.

## Claims

### Claim 1

An automated rapid antimicrobial susceptibility testing system for performing a multi-assay testing sequence, the system comprising:
one or more automated incubation assemblies comprising a nest assembly adapted to: i) house at least one test panel having a plurality of wells for receiving a sample comprising microorganisms originating from a clinical sample, and ii) facilitate incubation of one or more test panels in order to undergo the multi-assay testing sequence, the incubation assembly comprising:
one or more agitation systems configured to generate a repeated motion of the nest assemblies;
a sample separation assembly configured to separate microorganisms from a remainder of the sample within the wells of test panel, the sample separation assembly comprising a centrifugation system that forms a pellet of the microorganisms within the wells of the test panels;
a robotic handling assembly configured to accept one or more incoming test panels and move them between at least one of the one or more automated incubation assemblies and the separation assembly between each assay of the multi-assay testing sequence;
an automated liquid handling assembly configured to exchange one or more fluids in the plurality of wells of the test panels; and
an optical assembly for interrogation and readout of each assay of the multi-assay testing sequence being performed in the plurality of wells.

### Claim 2 (depends on 1)

The system of claim 1, wherein:
at least one nest assembly comprises a tiered frame comprising one or more floors, each floor comprising:
a stage to accommodate a test panel;
one or more cartridge positioning features extending from the stage; and
a set of recesses to accommodate a test panel handling device; and
the agitation system is configured to generate a repeated motion of the tiered frame.

### Claim 3 (depends on 2)

The system of claim 2 wherein the tiered frame comprises multiple floors where each floor comprises two surfaces to accommodate two test panels.

### Claim 4 (depends on 2)

The system of claim 2 wherein each floor comprises a heating element disposed in or along the stage.

### Claim 5 (depends on 1)

The system of claim 1 wherein incubation system assembly is heated using forced air.

### Claim 6 (depends on 1)

The system of claim 1 wherein the agitation system comprises a rotational agitation system comprising a rotating oscillating component.

### Claim 7 (depends on 6)

The system of claim 6 wherein the agitation system comprises one or more linear bearing surfaces.

### Claim 8 (depends on 7)

The system of claim 7 wherein the agitation system comprises two linear bearing surfaces positioned substantially perpendicularly with respect to one another and the agitation system comprises two sliding stages configured to slide along the bearing rails.

### Claim 9 (depends on 8)

The system of claim 8 wherein the agitation system is configured to agitate the nest assembly along an orbital path having a radius that is about 1 mm to about 12 mm.

### Claim 10 (depends on 1)

The system of claim 1 wherein the agitation system is configured to agitate the nest assembly along an orbital path and to vary a radius of the orbital path of agitation.

### Claim 11 (depends on 1)

The system of claim 1 wherein the agitation system is configured to agitate the nest assembly along an orbital path at a rate of about 50 revolutions per minute to about 650 revolutions per minute.

### Claim 12 (depends on 1)

The system of claim 1 wherein the robotic handling assembly is configured to move test panels between at least one of the one or more automated incubation assemblies and the optical assembly.

### Claim 13 (depends on 1)

The system of claim 1 wherein the robotic handling assembly is configured to move test panels between at least one of the one or more automated incubation assemblies and an area accessible by the automated liquid handling assembly.

### Claim 14 (depends on 1)

The system of claim 1 wherein the fluid handling assembly comprises at least one liquid addition system and an aspiration system.

### Claim 15 (depends on 14)

The system of claim 14 wherein reagents are stored in a disposable container.

### Claim 16 (depends on 1)

The system of claim 1 wherein the optical assembly is configured to measure at least one of nephelometry, absorbance, fluorescence, luminescence, time-resolved fluorescence, or time-gated luminescence emitted from the sample during the multi-assay testing sequence.

### Claim 17 (depends on 16)

The system of claim 16 wherein an excitation wavelength to generate a fluorescence emission is from about 545 nm to about 575 nm and a wavelength of the emission is from about 570 nm to about 610 nm.

### Claim 18 (depends on 16)

The system of claim 16 wherein an excitation wavelength to generate a time-gated luminescence emission is about 280 nm to about 360 nm and a wavelength of the emission is one or more of the following: about 545 nm, about 565 nm, from about 608 nm to about 623 nm, or about 645 nm.

### Claim 19 (depends on 1)

The system of claim 1 wherein the system is configured to yield a testing sequence throughput of at least 2, at least 4, at least 6, at least 8, at least 10, at least 12, at least 16, or at least 20 test panels per hour.

### Claim 20 (depends on 1)

The system of claim 1 wherein a time duration for processing a test panel through the testing sequence from insertion of the test panel into the system to obtaining a result is less than 8 hours, less than 6 hours, less than 5 hours, less than 4 hours, less than 3 hours, or less than 2 hours.

### Claim 21 (depends on 14)

The system of claim 14 wherein the fluid handling assembly comprises a manifold fluidly connected to at least one of the liquid addition system or the aspiration system, the manifold being configured to dispense and/or aspirate fluid using at least 8 tips.

### Claim 22

A method for performing multi-assay rapid antimicrobial susceptibility testing sequences, the method comprising:
inoculating a sample comprising a microorganism derived from a clinical sample into a plurality of wells of a test panel, at least a portion of the plurality of wells containing one or more antimicrobials of a plurality of antimicrobials for inoculation of the sample;
loading the test panel into an automated rapid antimicrobial susceptibility testing system for performing a multi-assay testing sequence; and
operating the testing system to:
move the loaded test panel to an incubation assembly comprising a nest assembly adapted to: i) house at least one test panel, and ii) facilitate incubation of one or more test panels in order to undergo the multi-assay testing sequence the incubation assembly comprising: an agitation system configured to generate a repeated motion of the nest assembly;
incubate and agitate the inoculated sample in the incubation assembly;
at least once, periodically measure an amount of sample growth in a plurality of control wells of the plurality of wells;
responsive to determining that a level of growth in the control wells meets or exceeds a threshold level of growth, stop incubation;
perform one or more end point assays on incubated samples in the test panel;
measure an optical output from the sample in the plurality of wells of the test panel, the optical output corresponding to an amount of the microorganism remaining in each of the plurality of wells; and
report at least one of: a minimum inhibitory concentration of and/or a qualitative susceptibility interpretation for the microorganism remaining in each of the plurality of wells and the plurality of antimicrobials.

### Claim 23 (depends on 22)

The method of claim 22 wherein the performing the end point assay comprises one or more of: liquid handling, centrifugation, incubation, or shaking of the sample.

### Claim 24 (depends on 23)

The method of claim 23 wherein the liquid handling comprises performing one or more aspiration and/or liquid addition steps.

### Claim 25 (depends on 24)

The method of claim 24 wherein the performing the end point assay comprises a plurality of binding steps.

### Claim 26 (depends on 25)

The method of claim 25 wherein an amplification species of the binding steps comprises at least one of: europium, terbium, samarium, or dysprosium.

### Claim 27 (depends on 22)

The method of claim 22 wherein the testing system is configured to process simultaneously at least 2, at least 4, at least 6, at least 8, at least 10, or at least 12 test panels.

### Claim 28 (depends on 22)

The method of claim 22 wherein the testing system is configured to yield a testing sequence throughput of at least 2, at least 4, at least 6, at least 8, at least 10, at least 12, or at least 16, at least 20 test panels per hour.

### Claim 29 (depends on 22)

The method of claim 22 wherein a time duration for processing a test panel through the testing sequence from insertion of the test panel into the testing system to obtaining a result is less than 8 hours, less than 6 hours, less than 5 hours, less than 4 hours, less than 3 hours, or less than 2 hours.

### Claim 30 (depends on 22)

The method of claim 22 wherein the test panel comprises a cartridge.
